iifl-logo

Mankind Pharma Ltd Historical Data

2,523.4
(-1.01%)
May 21, 2025|02:49:57 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd Historical Data

21/04/2025calendar-icon
21/05/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

21-Apr-2025

2,586.3

2,609.22,554.52,588.417,23588,46,92,110.32,35,153

22-Apr-2025

2,588.4

2,613.82,554.12,579.526,5521,18,80,01,857.23,49,877

23-Apr-2025

2,580

2,586.42,521.72,545.530,6961,06,42,01,654.22,81,356

24-Apr-2025

2,546.6

2,6292,5352,599.233,66397,80,55,583.62,11,545

25-Apr-2025

2,605

2,642.22,5252,557.530,2341,17,67,29,769.73,22,419

28-Apr-2025

2,537.5

2,5952,5202,560.416,83729,13,83,466.943,446

29-Apr-2025

2,560.4

2,598.52,539.92,556.912,98426,99,10,682.347,923

30-Apr-2025

2,565

2,584.82,425.62,465.344,4861,82,69,75,277.84,73,543

02-May-2025

2,467

2,4682,358.72,385.844,64191,01,29,837.21,90,646

05-May-2025

2,392.7

2,419.22,376.12,415.417,85728,98,44,890.561,709

06-May-2025

2,415.4

2,427.92,3502,368.731,45045,23,79,630.397,738

07-May-2025

2,335

2,442.52,3302,432.442,74675,71,76,5781,68,315

08-May-2025

2,432.4

2,478.72,3852,439.545,16666,85,63,3311,45,975

09-May-2025

2,390.6

2,433.32,370.52,408.230,0891,36,58,97,205.476,814

12-May-2025

2,459.9

2,528.42,4442,50025,0871,11,17,37,7083,23,694

13-May-2025

2,500

2,564.72,5002,547.332,2131,02,24,18,4722,89,313

14-May-2025

2,545

2,569.92,480.92,554.624,93277,53,22,394.41,90,966

15-May-2025

2,553.8

2,573.12,5162,559.923,54235,86,60,609.460,896

16-May-2025

2,561.9

2,5802,5322,572.713,69646,63,64,537.51,16,964

19-May-2025

2,580

2,6102,546.62,564.217,08890,39,49,008.12,81,928

20-May-2025

2,574

2,5872,525.42,549.229,64295,24,13,934.32,42,490

Mankind Pharma: Related NEWS

Mankind Pharma Faces ₹183.11 Crore Tax Demand
30 Mar 2025|04:34 PM

The cumulative demand, including interest charges, is ₹183.11 crore.

Read More
Mankind Pharma Merges Three Subsidiaries
30 Mar 2025|01:33 PM

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal
28 Feb 2025|11:13 PM

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

Read More
Top Stocks for Today - 24th January 2025
24 Jan 2025|07:50 AM

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%
23 Jan 2025|11:57 PM

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV
8 Jan 2025|04:01 PM

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

Read More
Mankind Pharma, Innovent Join Forces for Cancer Care
26 Dec 2024|12:46 PM

According to the National Cancer Registry Programme, cancer is expected to cause 29.8 million DALYs by 2025, making it a serious health issue in India.

Read More
Mankind Pharma Secures ₹3,000 Crore via QIP for Growth
20 Dec 2024|02:06 PM

The issue price includes a premium of ₹2,519 per share, aggregating a total of ₹2,999.99 crore.

Read More
Mankind Pharma Sees 30% Profit Surge in Q2
6 Nov 2024|10:12 PM

Revenue from operations grew by 13.6% YoY, totaling ₹3,076.5 Crore, up from ₹2,708.1 Crore in Q2 of the previous fiscal.

Read More
Top stocks for today - 6th November 2024
6 Nov 2024|08:08 AM

Here are some of the stocks that may see significant price movement today: Dr Reddy’s, Hindustan Zinc, Titan Company, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.